Eating less, especially in the beginning of using retatrutide, starts burning fat
Minnesota prescribers increasingly incorporate lipotropic therapy into tiered weight loss protocols: GLP-1 monotherapy for the first 12 weeks to establish appetite control and initial fat loss, then addition of weekly lipotropic injections when weight loss velocity drops below 0.5% of body weight per week despite continued medication adherence and dietary compliance
(2) More recent evidence suggests a potential for GLP-1 agonists in preventing age related disease in non-obese people too, as was demonstrated that its effect in reducing Alzheimer disease risk outweighed all other diabetes medications with similar risk reduction in normal weight and obese participants (3)
Review your administration schedule and discuss with your provider whether a dosage adjustment is appropriate
Or you can contact your plan administrator directly
The whole point of treating obesity is to improve those conditions, but while you are in the process, they are spending money on other medicines